Induction of thioredoxin-interacting protein is mediated by oxidative stress, calcium, and glucose after brain injury in mice

Neurobiology of Disease

Volumn 46, Issue 2, 2012, Pages 440-449

  Kim, Gab Seok ^a   Jung, Joo Eun ^a   Narasimhan, Purnima ^a   Sakata, Hiroyuki ^a   Chan, Pak H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Middle cerebral artery occlusion; Oxygen glucose deprivation; Polymerase chain reaction array; Reactive oxygen species; Thioredoxin; Thioredoxin interacting protein

Indexed keywords

3 NITROPROPIONIC ACID; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; GLUCOSE; LACTATE DEHYDROGENASE; MESSENGER RNA; SMALL INTERFERING RNA; THIOREDOXIN INTERACTING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; CONTROLLED STUDY; CYTOPLASM; ENZYME RELEASE; FEMALE; GENETIC TRANSFECTION; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REOXYGENATION; REPERFUSION INJURY;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN INJURIES; BRAIN ISCHEMIA; CALCIUM SIGNALING; CARRIER PROTEINS; CELLS, CULTURED; FEMALE; GLUCOSE; HYPERGLYCEMIA; MALE; MICE; OXIDATIVE STRESS; PREGNANCY; THIOREDOXINS;

EID: 84859504173     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.02.008     Document Type: Article

References (39)

1. Al-Mubarak B., Soriano F.X., Hardingham G.E. Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site. FOXO1 is a FOXO target gene. Channels 2009, 3:233-239.
2. Beal M.F., Ferrante R.J., Henshaw R., Matthews R.T., Chan P.H., Kowall N.W., Epstein C.J., Schulz J.B. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 1995, 65:919-922.
3. Bulkley G.B. Free radical-mediated reperfusion injury: a selective review. Br. J. Cancer Suppl. 1987, 8:66-73.
4. Cha-Molstad H., Saxena G., Chen J., Shalev A. Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells. J. Biol. Chem. 2009, 284:16898-16905.
5. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 2001, 21:2-14.
6. Chen K.-S., DeLuca H.F. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim. Biophys. Acta 1994, 1219:26-32.
7. Chen H., Kim G.S., Okami N., Narasimhan P., Chan P.H. NADPH oxidase is involved in post-ischemic brain inflammation. Neurobiol. Dis. 2011, 42:341-348.
8. de Candia P., Blekham R., Chabot A.E., Oshlack A., Gilad Y. A combination of genomic approaches reveals the role of FOXO1a in regulating an oxidative stress response pathway. PLoS One 2008, 3:e1670.
9. Fang S., Jin Y., Zheng H., Yan J., Cui Y., Bi H., Jia H., Zhang H., Wang Y., Na L., Gao X., Zhou H. High glucose condition upregulated Txnip expression level in rat mesangial cells through ROS/MEK/MAPK pathway. Mol. Cell. Biochem. 2011, 347:175-182.
10. Girouard H., Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J. Appl. Physiol. 2006, 100:328-335.
11. Hattori I., Takagi Y., Nakamura H., Nozaki K., Bai J., Kondo N., Sugino T., Nishimura M., Hashimoto N., Yodoi J. Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid. Redox Signal. 2004, 6:81-87.
12. Hwang I.K., Yoo K.-Y., Kim D.W., Lee C.H., Choi J.H., Kwon Y.-G., Kim Y.-M., Choi S.Y., Won M.-H. Changes in the expression of mitochondrial peroxiredoxin and thioredoxin in neurons and glia and their protective effects in experimental cerebral ischemic damage. Free Radic. Biol. Med. 2010, 48:1242-1251.
13. Jung J.E., Kim G.S., Chen H., Maier C.M., Narasimhan P., Song Y.S., Niizuma K., Katsu M., Okami N., Yoshioka H., Sakata H., Goeders C.E., Chan P.H. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol. Neurobiol. 2010, 41:172-179.
14. Kamada H., Yu F., Nito C., Chan P.H. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats. Relation to blood-brain barrier dysfunction. Stroke 2007, 38:1044-1049.
15. Kim G.W., Gasche Y., Grzeschik S., Copin J.-C., Maier C.M., Chan P.H. Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption?. J. Neurosci. 2003, 23:8733-8742.
16. Kim G.S., Jung J.E., Niizuma K., Chan P.H. CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia. J. Neurosci. 2009, 29:14779-14789.
17. Kirkland R.A., Windelborn J.A., Kasprzak J.M., Franklin J.L. A Bax-induced pro-oxidant state is critical for cytochrome c release during programmed neuronal death. J. Neurosci. 2002, 22:6480-6490.
18. Koháryová M., Kollárová M. Oxidative stress and thioredoxin system. Gen. Physiol. Biophys. 2008, 27:71-84.
19. Mehta S.L., Lin Y., Chen W., Yu F., Cao L., He Q., Chan P.H., Li P.A. Manganese superoxide dismutase deficiency exacerbates ischemic brain damage under hyperglycemic conditions by altering autophagy. Transl. Stroke Res. 2011, 2:42-50.
20. 2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol. Rev. 2008, 88:421-449.
21. Miller A.A., Dusting G.J., Roulston C.L., Sobey C.G. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke. Brain Res. 2006, 1111:111-116.
22. Minn A.H., Hafele C., Shalev A. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces β-cell apoptosis. Endocrinology 2005, 146:2397-2405.
23. Moro M.A., Almeida A., Bolaños J.P., Lizasoain I. Mitochondrial respiratory chain and free radical generation in stroke. Free Radic. Biol. Med. 2005, 39:1291-1304.
24. Patwari P., Higgins L.J., Chutkow W.A., Yoshioka J., Lee R.T. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J. Biol. Chem. 2006, 281:21884-21891.
25. Powis G., Montfort W.R. Properties and biological activities of thioredoxins. Annu. Rev. Biophys. Biomol. Struct. 2001, 30:421-455.
26. Rhee S.G., Chae H.Z., Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38:1543-1552.
27. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998, 17:2596-2606.
28. Saxena G., Chen J., Shalev A. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J. Biol. Chem. 2010, 285:3997-4005.
29. 3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ. Res. 2002, 91:689-695.
30. Schulze P.C., Yoshioka J., Takahashi T., He Z., King G.L., Lee R.T. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J. Biol. Chem. 2004, 279:30369-30374.
31. Sengupta A., Molkentin J.D., Paik J.-H., DePinho R.A., Yutzey K.E. FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J. Biol. Chem. 2011, 286:7468-7478.
32. Shalev A., Pise-Masison C.A., Radonovich M., Hoffmann S.C., Hirshberg B., Brady J.N., Harlan D.M. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFβ signaling pathway. Endocrinology 2002, 143:3695-3698.
33. Suh S.W., Shin B.S., Ma H., Van Hoecke M., Brennan A.M., Yenari M.A., Swanson R.A. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann. Neurol. 2008, 64:654-663.
34. Takagi Y., Mitsui A., Nishiyama A., Nozaki K., Sono H., Gon Y., Hashimoto N., Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:4131-4136.
35. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
36. Wang Q., Tompkins K.D., Simonyi A., Korthuis R.J., Sun A.Y., Sun G.Y. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res. 2006, 1090:182-189.
37. Watson W.H., Yang X., Choi Y.E., Jones D.P., Kehrer J.P. Thioredoxin and its role in toxicology. Toxicol. Sci. 2004, 78:3-14.
38. Yamanaka H., Maehira F., Oshiro M., Asato T., Yanagawa Y., Takei H., Nakashima Y. A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system. Biochem. Biophys. Res. Commun. 2000, 271:796-800.
39. Yu F.-X., Luo Y. Tandem ChoRE and CCAAT motifs and associated factors regulate Txnip expression in response to glucose or adenosine-containing molecules. PLoS One 2009, 4:e8397.